CRISPR Explained
How Bacteria Invented the Most Powerful Editing Tool in Biology
The molecular scissors now being used to rewrite human DNA were first discovered not in a lab, but inside the ancient immune systems of bacteria.
The Idea
CRISPR — short for Clustered Regularly Interspaced Short Palindromic Repeats — sounds like an acronym engineered to win a jargon competition, but the underlying idea is almost elegantly simple. Bacteria, it turns out, have a primitive immune memory. When a virus attacks, some bacteria survive by snipping out a piece of the virus's genetic code and storing it in their own DNA — a molecular wanted poster. If the same virus attacks again, the bacterium deploys a protein called Cas9, guided by a matching RNA sequence, to find and cut that exact stretch of viral DNA. Game over for the virus. When biochemists Jennifer Doudna and Emmanuelle Charpentier realised in 2012 that this system could be reprogrammed — that you could swap in any DNA sequence as the guide and point Cas9 at virtually any gene in any organism — the implications were staggering. You could now edit the genome of a living cell with a precision that previous tools couldn't approach. Earlier gene-editing techniques were slower, less accurate, and far more expensive. CRISPR made the same work faster by orders of magnitude, cheaper, and reproducible enough that a well-equipped university lab could do it. What CRISPR does, at its core, is find a specific address in a three-billion-letter genetic code, make a clean cut, and then let the cell's own repair mechanisms either disable that gene or insert a new sequence in its place. The guide RNA is the GPS. Cas9 is the scissors. The cell does the rest.
In the World
In 2023, the world got its first real proof that CRISPR could move from the lab bench to the human body and actually work. The US Food and Drug Administration approved a treatment called Casgevy — developed by Vertex Pharmaceuticals and CRISPR Therapeutics — for sickle cell disease and beta-thalassemia, two devastating inherited blood disorders caused by a single faulty gene. Sickle cell disease affects the shape of red blood cells, causing them to snag in blood vessels, cut off oxygen, and produce episodes of severe pain that can last for days. For decades, the only cure was a bone marrow transplant — which required a matched donor and carried serious risks. Casgevy works differently. Doctors extract a patient's own stem cells, use CRISPR in a lab dish to edit a gene that reactivates fetal haemoglobin (a form the body naturally switches off after birth), and then infuse the edited cells back in. Fetal haemoglobin compensates for the broken adult version. In clinical trials, nearly all participants were freed from the severe pain crises that had defined their lives. One patient, Victoria Gray, became the first person in the United States to receive a CRISPR-based treatment back in 2019, as part of the trial. NPR followed her story for years. By 2023, she was describing a life she didn't think was possible — camping with her kids, working, living without the shadow of the next crisis. A bacterium's immune trick, repurposed, had rewritten the story of her body.
Why It Matters
CRISPR matters well beyond medicine, though medicine is where it becomes most viscerally real. It's already being used to engineer crops that survive drought, to develop diagnostics that can detect a pathogen in minutes, and to explore gene drives that could theoretically eliminate malaria-carrying mosquito populations from entire regions — which opens questions that are as much ethical as scientific. The technology also forces a sharper version of a question we tend to leave vague: what is a disease, and what is simply human variation? If you can edit the gene associated with hereditary deafness, should you? Many in the Deaf community would say no — that deafness is a culture, not a condition. CRISPR doesn't answer that question. It makes it impossible to avoid. Then there's the boundary between treating illness and enhancing capability — a line that looked theoretical until it didn't. In 2018, Chinese scientist He Jiankui secretly edited the embryos of twin girls, claiming to confer resistance to HIV. He was imprisoned. The twins are now children somewhere in the world, carrying edits no one fully understands yet. Knowing how CRISPR works won't resolve those dilemmas. But it means you can engage with them rather than defer to whoever speaks most confidently.
A Question to Ponder
If you could know with certainty that a single gene edit would eliminate a serious heritable condition from your family line forever — would you want that choice available, and who should get to make it?
Get a new one of these every morning.
Start learning with Thinkable